Literature DB >> 30610100

Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders.

Susanne W Duvall1, Olivia Lindly2,3, Katharine Zuckerman2,4,5, Michael E Msall6,7, Melissa Weddle2.   

Abstract

Children with autism spectrum disorder (ASD) are at risk for self-injurious behaviors that can be difficult to treat in the context of co-occurring low IQ and adaptive skills. Increased prevalence and decriminalization of cannabis in some states have led to more frequent questions for pediatricians about the use of cannabis for difficult-to-treat developmental and behavioral conditions. What do we know about the possible benefits and risks of cannabis use in children with ASD? How should the clinician respond to a parent who expresses interest in cannabis to manage behavior in a child with ASD? Ethical analysis that includes harm reduction, health concerns, and information sharing will be discussed. We present commentary on the ethical implications of cannabis use in children with ASD and severe self-harm behaviors.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30610100      PMCID: PMC7250053          DOI: 10.1542/peds.2018-0558

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  43 in total

1.  Establishing a translational science for autistic spectrum disorders for children and their families: optimizing function, participation, and well-being.

Authors:  Michael E Msall
Journal:  J Pediatr       Date:  2009-03       Impact factor: 4.406

Review 2.  The impact of marijuana policies on youth: clinical, research, and legal update.

Authors: 
Journal:  Pediatrics       Date:  2015-01-26       Impact factor: 7.124

3.  Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study.

Authors:  Roger S Akins; Paula Krakowiak; Kathleen Angkustsiri; Irva Hertz-Picciotto; Robin L Hansen
Journal:  J Dev Behav Pediatr       Date:  2014-01       Impact factor: 2.225

4.  Cognitive ability is associated with different outcome trajectories in autism spectrum disorders.

Authors:  Esther Ben-Itzchak; Linda R Watson; Ditza A Zachor
Journal:  J Autism Dev Disord       Date:  2014-09

Review 5.  Parental refusals of medical treatment: the harm principle as threshold for state intervention.

Authors:  Douglas S Diekema
Journal:  Theor Med Bioeth       Date:  2004

Review 6.  Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.

Authors:  Scott E Hadland; John R Knight; Sion K Harris
Journal:  J Dev Behav Pediatr       Date:  2015 Feb-Mar       Impact factor: 2.225

Review 7.  A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders.

Authors:  Johnny L Matson; Santino V Lovullo
Journal:  Behav Modif       Date:  2008-01

8.  Prevalence and Predictors of Complementary and Alternative Medicine Use in a Large Insured Sample of Children with Autism Spectrum Disorders.

Authors:  Ashli A Owen-Smith; Stephen Bent; Frances L Lynch; Karen J Coleman; Vincent M Yau; Kathryn A Pearson; Maria L Massolo; Virginia Quinn; Lisa A Croen
Journal:  Res Autism Spectr Disord       Date:  2015-09-01

9.  Family impacts among children with autism spectrum disorder: the role of health care quality.

Authors:  Katharine E Zuckerman; Olivia J Lindly; Christina D Bethell; Karen Kuhlthau
Journal:  Acad Pediatr       Date:  2014 Jul-Aug       Impact factor: 3.107

10.  Medication use among children with autism spectrum disorders.

Authors:  Donald P Oswald; Neil A Sonenklar
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-06       Impact factor: 2.576

View more
  7 in total

1.  Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.

Authors:  Richard Holdman; Daniel Vigil; Kelsey Robinson; Puja Shah; Alexandra Elyse Contreras
Journal:  Cannabis Cannabinoid Res       Date:  2021-08-24

2.  Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.

Authors:  Majd Al-Soleiti; Kayla Balaj; Robyn P Thom; Christopher J McDougle; Christopher J Keary
Journal:  J Autism Dev Disord       Date:  2021-09-09

Review 3.  Post-diagnostic management and follow-up care for autism spectrum disorder.

Authors:  Angie Ip; Lonnie Zwaigenbaum; Jessica A Brian
Journal:  Paediatr Child Health       Date:  2019-10-24       Impact factor: 2.253

4.  Clinician views on and ethics priorities for authorizing medical cannabis in the care of children and youth in Canada: a qualitative study.

Authors:  Margot Gunning; Ari D Rotenberg; Lauren E Kelly; Bruce Crooks; Sapna Oberoi; Adam L Rapoport; S Rod Rassekh; Judy Illes
Journal:  CMAJ Open       Date:  2022-03-15

Review 5.  Medicinal Use of Cannabis in Children and Pregnant Women.

Authors:  Gideon Koren; Rana Cohen
Journal:  Rambam Maimonides Med J       Date:  2020-01-30

6.  Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study.

Authors:  Micha Hacohen; Orit E Stolar; Matitiahu Berkovitch; Odelia Elkana; Elkana Kohn; Ariela Hazan; Eli Heyman; Yael Sobol; Danel Waissengreen; Eynat Gal; Ilan Dinstein
Journal:  Transl Psychiatry       Date:  2022-09-09       Impact factor: 7.989

Review 7.  Current state of evidence of cannabis utilization for treatment of autism spectrum disorders.

Authors:  Rumi Agarwal; Shanna L Burke; Marlaina Maddux
Journal:  BMC Psychiatry       Date:  2019-10-29       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.